Advertisement

International Urology and Nephrology

, Volume 27, Issue 1, pp 1–8 | Cite as

Surgical treatment of renal cell carcinoma metastases: Prognostic significance

  • M. Takashi
  • Y. Takagi
  • T. Sakata
  • T. Shimoji
  • K. Miyake
Article

Abstract

Between January 1980 and March 1993, 166 patients with renal cell carcinoma were treated at Nagoya University Hospital. Among them 16 (9.6%) underwent surgical removal of 21 metastatic lesions: 12 patients had distant metastases at diagnosis and the other 4 demonstrated new distant metastases during their clinical course after nephrectomy. The metastatic lesions involved the brain in 6 patients, bone in 4, lung in 2, contralateral adrenal glands in 2, soft tissues in 2, lymph nodes in 2, pleura in 1, pancreas in 1, and contralateral renal pelvis in 1. All of the 16 patients underwent nephrectomy and 15 of them (93%) received interferon-α therapy. Patients with lesions which were completely resected had significantly longer survival than those with lesions which were palliatively treated and those with metastatic lesions at other sites (p=0.02). Improvement of performance status was observed in 5 of 6 (83%) patients undergoing palliative surgical treatment. The present study suggests that surgical removal of metastatic lesions prolongs survival in a limited number of renal cell carcinoma patients and that it improves performance status in those symptoms related to metastasis.

Keywords

Renal Cell Carcinoma Metastatic Lesion International Urology Metastatic Renal Cell Carcinoma Renal Cell Carcinoma Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Skinner, D. G., Colvin, R. B., Vermillion, C. D., Pfister, R. C., Leadbetter, W. F.: Diagnosis and management of renal cell carcinoma: A clinical and pathologic study of 309 cases.Cancer, 28, 1165 (1971).CrossRefPubMedGoogle Scholar
  2. 2.
    Takashi, M., Nakano, Y., Sakata, T., Miyake, K., Hamajima, N.: Multivariate evaluation of prognostic determinants for renal cell carcinoma.Urol. Int., 50, 6 (1993).CrossRefPubMedGoogle Scholar
  3. 3.
    Montie, J. E., Stewart, B. H., Straffon, R. A., Banowsky, L. H. W., Hewitt, C. B., Montague, D. K.: The role of adjunctive nephrectomy in patients with metastatic renal cell carcinoma.J. Urol., 117, 272 (1977).PubMedGoogle Scholar
  4. 4.
    Quesada, J. R.: Role of interferons in the therapy of metastatic renal cell carcinoma.Urology, 34 (Suppl.), 80 (1989).CrossRefPubMedGoogle Scholar
  5. 5.
    Middleton, R. G.: Surgery for metastatic renal cell carcinoma.J. Urol., 97, 973 (1967).PubMedGoogle Scholar
  6. 6.
    Tolia, B. M., Whitmore, W. F. Jr.: Solitary metastasis from renal cell carcinoma.J. Urol., 114, 836 (1975).PubMedGoogle Scholar
  7. 7.
    deKernion, J. B., Ramming, K. P., Smith, R. B.: The natural history of metastatic renal cell carcinoma: A computer analysis.J. Urol., 120, 148 (1978).PubMedGoogle Scholar
  8. 8.
    O'dea, M. J., Zincke, H., Utz, D. C., Bernatz, P. E.: The treatment of renal cell carcinoma with solitary metastasis.J. Urol., 120, 540 (1978).PubMedGoogle Scholar
  9. 9.
    Golimbu, M., Al-Askari, S., Tessler, A., Morales, P.: Aggressive treatment of metastatic renal cancer.J. Urol., 136, 805 (1986).PubMedGoogle Scholar
  10. 10.
    Hermanek, P., Sobin, L. H.: TNM Classification of Malignant Tumours. 4th ed. Springer-Verlag, Berlin 1987.Google Scholar
  11. 11.
    Skeel, R. T.: Systematic assessment of the patient with cancer. In: Skeel, R. T. (ed.). Handbook of Cancer Chemotherapy. 2nd ed. Little Brown, Boston 1987, pp. 15–24.Google Scholar
  12. 12.
    Kaplan, E. L., Meier, P.: Nonparametric estimation from incomplete observations.J. Am. Stat. Assoc., 53, 457 (1958).CrossRefGoogle Scholar
  13. 13.
    Gehan, E. A.: A generalized Wilcoxon test for comparing arbitrarily single-censored samples.Biometrika, 52, 203 (1965).PubMedGoogle Scholar
  14. 14.
    Takashi, M., Sakata, T., Sai, Y., Shimoji, T., Miyake, K.: Metastasis of renal cell carcinoma to the contralateral renal pelvis.Urol. Int., 51, 102 (1993).CrossRefPubMedGoogle Scholar
  15. 15.
    Selli, C., Hinshaw, W. M., Woodard, B. H., Paulson, D. F.: Stratification of risk factors in renal cell carcinoma.Cancer, 52, 899 (1983).CrossRefPubMedGoogle Scholar
  16. 16.
    Siminovitch, J. M. P., Montie, J. E., Straffon, R. A.: Prognostic indicators in renal cell adenocarcinoma.J. Urol., 130, 20 (1983).PubMedGoogle Scholar
  17. 17.
    Takashi, M., Sakata, T., Nakano, Y., Nagai, T., Takaba, H., Tanaka, J., Okamura, K., Takamura, S., Kanai, S., Sahashi, M., Murase, T., Shimoji, T., Miyake, K.: Clinical characteristics and prognosis of renal cell carcinoma: Statistical evaluation of possible determinants for distant metastasis, venous tumor thrombi, and lymph node metastasis.Jpn. J. Urol., 83, 321 (1992).Google Scholar
  18. 18.
    Neves, R. J., Zincke, H., Taylor, W. F.: Metastatic renal cell cancer and radical nephrectomy: Identification of prognostic factors and patient survival.J. Urol., 139, 1173 (1988).PubMedGoogle Scholar
  19. 19.
    Krown, S. E.: Interferon treatment of renal cell carcinoma: Current status and future prospects.Cancer, 59, 647 (1987).CrossRefPubMedGoogle Scholar
  20. 20.
    Dreicer, R., Williams, R. D.: Renal parenchymal neoplasms. In: Tanagho, E. A., McAninch, J. W. (eds): Smith's General Urology. 13th ed. Appleton & Lange, Norwalk 1992, pp. 359–377.Google Scholar
  21. 21.
    Sella, A., Swanson, D. A., Ro, J. A., Putnam, J. B., Jr., Amato, R. J., Markowitz, A. B., Logothetis, C. J.: Surgery following response to interferon-α-based therapy for residual renal cell carcinoma.J. Urol., 149, 19 (1993).PubMedGoogle Scholar
  22. 22.
    Tanioka, F., Hiroi, M., Moriki, T., Yamashita, M., Yamane, T., Hara, H., Iijima, S.: Proliferating cell nuclear antigen (PCNA). Immunostaining in renal cell carcinoma and its relationship to tumor grading, flow cytometric DNA analysis and prognosis.GBK Fortbild. aktuel. Krebsdiagn. Therap., 62, 17 (1992).Google Scholar

Copyright information

© Akadémiai Kiadó 1995

Authors and Affiliations

  • M. Takashi
    • 1
  • Y. Takagi
    • 1
  • T. Sakata
    • 1
  • T. Shimoji
    • 1
  • K. Miyake
    • 1
  1. 1.Department of UrologyNagoya University School of MedicineNagoyaJapan

Personalised recommendations